Lasofoxifene and ER+ Breast Cancer: Breakthroughs in Bone Metastasis Therapy

In this episode, we explore the latest advances in treating estrogen receptor-positive (ER+) breast cancer, with a spotlight on lasofoxifene, a next-generation hormonal therapy showing promise for patients with advanced disease and bone metastasis. You’ll learn: Why is such a common site for ER+ breast cancer metastasisHow traditional endocrine therapies can weaken bone health and impact quality of lifeThe unique dual action of lasofoxifene in both breast and bone tissueKey insights from the ...